Nephros (NEPH) FCF Margin (2010 - 2026)
Nephros' quarterly FCF Margin came in at 32.06% in Q1 2026, down 3866.0% year-on-year from 0.85% in Q1 2025, and down 919.54% quarter-over-quarter from 3.91% in Q4 2025.
Nephros has reported FCF Margin for 17 years, with the latest figure at 32.06% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin fell 3866.0% year-over-year to 32.06%; the trailing twelve-month figure through Mar 2026 stood at 2.06% (down 529.0% YoY), and the FY2025 full-year result was 8.52%, up 1238.0% from the prior year.
- FCF Margin for Q1 2026 stood at 32.06%, down from 3.91% in the prior quarter.
- The five-year high for FCF Margin was 33.7% in Q4 2024, with the low at 84.81% in Q1 2022.
- Average FCF Margin over 5 years is 7.92%, with a median of 7.06% recorded in 2022.
- Year-over-year, FCF Margin plunged 8196 bps in 2022 and surged 9227 bps in 2023.
- Tracing NEPH's FCF Margin over 5 years: stood at 7.62% in 2022, then grew by 4 bps to 7.28% in 2023, then soared by 563 bps to 33.7% in 2024, then slumped by 88 bps to 3.91% in 2025, then plunged by 920 bps to 32.06% in 2026.
- The last three FCF Margin figures came in at 32.06% (Q1 2026), 3.91% (Q4 2025), and 2.08% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 29.18% |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 11.58% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 36.36% |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 7.55% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | -13.60% |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 15.50% |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 11.56% |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 2.81% |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 5.42% |
| 10 | Nephros | 38.93 Mn | 34.91 Mn | 2.99 Mn | -32.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.06% |
| Dec 31, 2025 | 3.91% |
| Sep 30, 2025 | 2.08% |
| Jun 30, 2025 | 22.49% |
| Mar 31, 2025 | 6.60% |
| Dec 31, 2024 | 33.70% |
| Sep 30, 2024 | -17.71% |
| Jun 30, 2024 | -15.41% |
| Mar 31, 2024 | -19.08% |
| Dec 31, 2023 | -7.28% |
| Sep 30, 2023 | 15.02% |
| Jun 30, 2023 | 6.38% |
| Mar 31, 2023 | 7.47% |
| Dec 31, 2022 | -7.62% |
| Sep 30, 2022 | -7.06% |
| Jun 30, 2022 | -41.23% |
| Mar 31, 2022 | -84.81% |
| Dec 31, 2021 | -12.35% |
| Sep 30, 2021 | -35.80% |
| Jun 30, 2021 | -5.16% |
| Mar 31, 2021 | -2.85% |
| Dec 31, 2020 | -65.38% |
| Sep 30, 2020 | -86.28% |
| Jun 30, 2020 | -109.07% |
| Mar 31, 2020 | -72.76% |
| Dec 31, 2019 | 11.52% |
| Sep 30, 2019 | -19.84% |
| Jun 30, 2019 | -57.56% |
| Mar 31, 2019 | -39.40% |
| Dec 31, 2018 | -32.75% |
| Sep 30, 2018 | -65.08% |
| Jun 30, 2018 | -98.32% |
| Mar 31, 2018 | -67.92% |
| Dec 31, 2017 | 138.00% |
| Sep 30, 2017 | -77.84% |
| Jun 30, 2017 | -58.09% |
| Mar 31, 2017 | -95.51% |
| Dec 31, 2016 | -70.87% |
| Sep 30, 2016 | -195.33% |
| Jun 30, 2016 | -56.19% |
| Mar 31, 2016 | -100.55% |
| Dec 31, 2015 | -347.34% |
| Sep 30, 2015 | -351.25% |
| Jun 30, 2015 | -94.18% |
| Mar 31, 2015 | -174.00% |
| Dec 31, 2014 | -242.98% |
| Sep 30, 2014 | -267.45% |
| Jun 30, 2014 | -55.56% |
| Mar 31, 2014 | -131.50% |
| Dec 31, 2013 | 116.25% |
| Sep 30, 2013 | -33.01% |
| Jun 30, 2013 | -283.30% |
| Mar 31, 2013 | -178.31% |
| Dec 31, 2012 | -52.34% |
| Sep 30, 2012 | -163.70% |
| Jun 30, 2012 | -263.91% |
| Mar 31, 2012 | 118.06% |
| Dec 31, 2011 | -91.27% |
| Sep 30, 2011 | 185.91% |
| Jun 30, 2011 | -84.77% |
| Mar 31, 2011 | -80.47% |
| Dec 31, 2010 | -130.56% |
| Sep 30, 2010 | 12.54% |